✦ LIBER ✦

Enriching Amnestic Mild Cognitive Impairment Populations for Clinical Trials: Optimal Combination of Biomarkers to Predict Conversion to Dementia

✍ Scribed by Yu, Peng ;Dean, Robert A. ;Hall, Stephen D. ;Qi, Yuan ;Sethuraman, Gopalan ;Willis, Brian A. ;Siemers, Eric R. ;Martenyi, Ferenc ;Tauscher, Johannes T. ;Schwarz, Adam J. ;,

Book ID: 118054884
Publisher: IOS Press
Year: 2012
Tongue: English
Weight: 253 KB
Volume: 32
Category: Article
ISSN: 1387-2877
DOI: 10.3233/jad-2012-120832

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of biomarkers to select the target p

Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment

✍ P. J. Visser 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 49 KB

Accuracy of different biomarkers to pred

Accuracy of different biomarkers to predict progression from mild cognitive impairment to probable Alzheimer's dementia in two independent clinical series

✍ Annapaola Prestia; Anna Caroli; Karl Herholz; Eric Reiman; William Jagust; Kewei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Annual conversion to Alzheimer disease a

Annual conversion to Alzheimer disease among patients with memory complaints attending an outpatient memory clinic: the influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing

✍ Johann Lehrner; Renate Gufler; Giselher Guttmann; Joachim Maly; Andreas Gleiß; E 📂 Article 📅 2005 🏛 Springer Vienna 🌐 English ⚖ 73 KB

Progranulin plasma levels as potential b

Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease

✍ Miryam Carecchio; Chiara Fenoglio; Milena De Riz; Ilaria Guidi; Cristoforo Comi; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 176 KB